n-formylmethionine leucyl-phenylalanine and Hodgkin Disease

n-formylmethionine leucyl-phenylalanine has been researched along with Hodgkin Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bayssas, M; Blaise, D; Fossat, C; Juhan-Vague, I; Maraninchi, D; Sainty, D; Stoppa, AM; Viens, P; Yver, A1

Trials

1 trial(s) available for n-formylmethionine leucyl-phenylalanine and Hodgkin Disease

ArticleYear
In vivo stimulation of neutrophil function by lenograstim (glycosylated rHuG-CSF) in oncohematologic patients: results of a phase I trial.
    Stem cells (Dayton, Ohio), 1994, Volume: 12, Issue:3

    Topics: Adult; Cell Adhesion; Chemotaxis, Leukocyte; Female; Granulocyte Colony-Stimulating Factor; Granulocytes; Hodgkin Disease; Humans; In Vitro Techniques; Lenograstim; Leukocyte Count; Leukocyte Elastase; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Muramidase; N-Formylmethionine Leucyl-Phenylalanine; Neoplasms; Neutrophils; Pancreatic Elastase; Phagocytosis; Recombinant Proteins

1994